{"id":463,"date":"2026-08-28T06:56:05","date_gmt":"2026-08-28T06:56:05","guid":{"rendered":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"survodutide-glucagon-glp-1-research-status-and-material-identity","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/es\/survodutide-glucagon-glp-1-research-status-and-material-identity\/","title":{"rendered":"Estado de la investigaci\u00f3n Survodutide: Biolog\u00eda, ensayos e identidad del material dual glucag\u00f3n\/GLP-1"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">Survodutide es un receptor dual de glucag\u00f3n y un agonista del receptor GLP-1 en desarrollo cl\u00ednico. \u201cAgonista dual\u201d describe la farmacolog\u00eda del receptor; no es un certificado de estado cl\u00ednico ni prueba de que dos materiales con el mismo nombre corto sean equivalentes.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Lo que muestra el registro<\/h2><ul class=\"wp-block-list\"><li>Los resultados de la fase 2 y de la fase 3 deben atribuirse a la formulaci\u00f3n y poblaci\u00f3n estudiadas.<\/li><li>El art\u00edculo 2026 fase 3 todav\u00eda describe la survodutida como en investigaci\u00f3n.<\/li><li>Los controles de secuencia, contrai\u00f3n, pureza, contenido e impurezas siguen siendo cuestiones espec\u00edficas de los lotes.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/survodutide-dual-receptor-research-20260828.png\" alt=\"Cient\u00edfico revisando datos de ensayos metab\u00f3licos y dos v\u00edas de se\u00f1alizaci\u00f3n de receptores\" class=\"wp-image-457\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/survodutide-dual-receptor-research-20260828.png 1536w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/survodutide-dual-receptor-research-20260828-300x200.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/survodutide-dual-receptor-research-20260828-1024x683.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/survodutide-dual-receptor-research-20260828-768x512.png 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><figcaption class=\"wp-element-caption\">Ilustraci\u00f3n editorial original utilizada para identificar el tema de la investigaci\u00f3n. No representa un lote de cat\u00e1logo, medicamento aprobado, resultado de ensayo o uso cl\u00ednico.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">La frontera entre identidad y evidencia<\/h2><p class=\"wp-block-paragraph\">El programa de fase 2 estableci\u00f3 una se\u00f1al de rango de dosis, mientras que SYNCHRONIZE-1 proporcion\u00f3 el primer resultado de obesidad de fase 3 publicado. Esos registros responden preguntas sobre el desarrollo cl\u00ednico. No responden si un lote de cat\u00e1logo tiene la misma secuencia, formulaci\u00f3n, perfil de exposici\u00f3n o controles de fabricaci\u00f3n.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Perfil del receptor<\/strong><span>Receptor de glucag\u00f3n + agonismo del receptor GLP-1<\/span><\/div><div class=\"pim-evidence-row\"><strong>Ancla de evidencia actual<\/strong><span>SYNCHRONIZE-1, NCT06066515<\/span><\/div><div class=\"pim-evidence-row\"><strong>L\u00edmite del cat\u00e1logo<\/strong><span>No hay inferencia de equivalencia entre la formulaci\u00f3n del ensayo y la formulaci\u00f3n.<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Qu\u00e9 pertenece al registro de materiales<\/h2><p class=\"wp-block-paragraph\">Para la adquisici\u00f3n de investigaciones, registre la secuencia exacta y la forma molecular, el contenido de p\u00e9ptidos, el m\u00e9todo cromatogr\u00e1fico, la confirmaci\u00f3n de masa, la informaci\u00f3n de agua y contrai\u00f3n, y cualquier requisito de agregaci\u00f3n o impureza. Evite describir un material de investigaci\u00f3n como la intervenci\u00f3n cl\u00ednica sin vinculaci\u00f3n documental.<\/p><h2 class=\"wp-block-heading\">Regla editorial<\/h2><p class=\"wp-block-paragraph\">Utilice el nombre exacto de la intervenci\u00f3n, el modelo, la poblaci\u00f3n y el criterio de valoraci\u00f3n del registro citado. No convierta una asociaci\u00f3n, mecanismo, resultado en animales, registro de medicamento terminado aprobado o prueba anal\u00edtica en una afirmaci\u00f3n sobre un lote de cat\u00e1logo no relacionado.<\/p>","protected":false},"excerpt":{"rendered":"<p>Survodutide es un receptor dual de glucag\u00f3n y un agonista del receptor GLP-1 en desarrollo cl\u00ednico. \u201cAgonista dual\u201d describe la farmacolog\u00eda del receptor; no es un certificado de estado cl\u00ednico ni prueba de que dos materiales con el mismo nombre corto sean equivalentes.<\/p>","protected":false},"author":1,"featured_media":628,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"365","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"Phase 2 and phase 3 records; development and identity review","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"Survodutide Once Weekly for Adults with Obesity \u2014 SYNCHRONIZE-1\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/42253238\/\",\"note\":\"2026 phase 3 primary record; PMID 42253238.\"},{\"title\":\"Survodutide phase 2 obesity trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38330987\/\",\"note\":\"Dose-ranging clinical context; PMID 38330987.\"},{\"title\":\"ClinicalTrials.gov NCT06066515\",\"url\":\"https:\/\/clinicaltrials.gov\/study\/NCT06066515\",\"note\":\"Registry record for SYNCHRONIZE-1.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-463","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Survodutide Research Status: Trials &amp; Material Identity<\/title>\n<meta name=\"description\" content=\"Survodutide is a dual glucagon-receptor and GLP-1-receptor agonist in clinical development. \u201cDual agonist\u201d describes receptor pharmacology; it is not a cer\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/es\/survodutide-glucagon-glp-1-research-status-and-material-identity\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Survodutide Research Status: Dual Glucagon\/GLP-1 Biology, Trials and Material Identity\" \/>\n<meta property=\"og:description\" content=\"Survodutide is a dual glucagon-receptor and GLP-1-receptor agonist in clinical development. \u201cDual agonist\u201d describes receptor pharmacology; it is not a cer\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/es\/survodutide-glucagon-glp-1-research-status-and-material-identity\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Survodutide Research Status: Dual Glucagon\\\/GLP-1 Biology, Trials and Material Identity\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/\"},\"wordCount\":250,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/\",\"name\":\"Survodutide Research Status: Trials & Material Identity\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"Survodutide is a dual glucagon-receptor and GLP-1-receptor agonist in clinical development. \u201cDual agonist\u201d describes receptor pharmacology; it is not a cer\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/survodutide-glucagon-glp-1-research-status-and-material-identity\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Survodutide Research Status: Dual Glucagon\\\/GLP-1 Biology, Trials and Material Identity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/es\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Estado de la investigaci\u00f3n Survodutide: ensayos e identidad del material","description":"Survodutide es un receptor dual de glucag\u00f3n y un agonista del receptor GLP-1 en desarrollo cl\u00ednico. \u201cAgonista dual\u201d describe la farmacolog\u00eda del receptor; no es un cer...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/es\/survodutide-glucagon-glp-1-research-status-and-material-identity\/","og_locale":"es_ES","og_type":"article","og_title":"Survodutide Research Status: Dual Glucagon\/GLP-1 Biology, Trials and Material Identity","og_description":"Survodutide is a dual glucagon-receptor and GLP-1-receptor agonist in clinical development. \u201cDual agonist\u201d describes receptor pharmacology; it is not a cer\u2026","og_url":"https:\/\/nhdbio.com\/es\/survodutide-glucagon-glp-1-research-status-and-material-identity\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:05+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Survodutide Research Status: Dual Glucagon\/GLP-1 Biology, Trials and Material Identity","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/"},"wordCount":250,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/","url":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/","name":"Estado de la investigaci\u00f3n Survodutide: ensayos e identidad del material","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"Survodutide es un receptor dual de glucag\u00f3n y un agonista del receptor GLP-1 en desarrollo cl\u00ednico. \u201cAgonista dual\u201d describe la farmacolog\u00eda del receptor; no es un cer...","breadcrumb":{"@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/survodutide-glucagon-glp-1-research-status-and-material-identity-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/survodutide-glucagon-glp-1-research-status-and-material-identity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Survodutide Research Status: Dual Glucagon\/GLP-1 Biology, Trials and Material Identity"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Materias primas pept\u00eddicas y s\u00edntesis personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipo t\u00e9cnico de NHD","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"El equipo t\u00e9cnico de NHD mantiene documentaci\u00f3n del cat\u00e1logo de uso de investigaci\u00f3n y res\u00famenes de evidencia. Los art\u00edculos revisados \u200b\u200benlazan con art\u00edculos revisados \u200b\u200bpor pares, registros de ensayos y registros regulatorios, conservan hallazgos nulos y limitaciones de estudios, y distinguen las intervenciones publicadas de los materiales del cat\u00e1logo. Se puede utilizar dibujo asistido por AI para la estructura; los enlaces de fuentes y los l\u00edmites de las pruebas permanecen visibles. Este trabajo no es una revisi\u00f3n por pares independiente ni un consejo m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/es\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/comments?post=463"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/463\/revisions"}],"predecessor-version":[{"id":513,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/posts\/463\/revisions\/513"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media\/628"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/media?parent=463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/categories?post=463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/es\/wp-json\/wp\/v2\/tags?post=463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}